Neuro-11:a new questionnaire for the assessment of somatic symptom disorder in general hospitals  

作　　者：Silin Zeng Yian Yu Shan Lu Sirui Zhang Xiaolin Su Ge Dang Ying Liu Zhili Cai Siyan Chen Yitao He Xin Jiang Chanjuan Chen Lei Yuan Peng Xie Jianqing Shi Qingshan Geng Rafael H Llinas Yi Guo 

机构地区：[1]Department of Neurology,Shenzhen People's Hospital,The second Affiliated Hospitals of Jinan University,The first Affiliated Hospitals of Southern University of Science and Technology,Shenzhen,Guangdong,China [2]Jinan University,Guangzhou,Guangdong,China [3]Department of Statistics and Data Science,Southern University of Science and Technology,Shenzhen,Guangdong,China [4]Institute of Neurological Diseases,Shenzhen Bay Laboratory,Shenzhen,Guangdong,China [5]Department of neurology,The Johns Hopkins University School of Medicine,Baltimore,Maryland,USA [6]Department of Geriatrics,Shenzhen People's Hospital,The second Affiliated Hospitals of Jinan University,The first Affiliated Hospitals of Southern University of Science and Technology,Shenzhen,China [7]NHC Key Laboratory of Diagnosis and Treatment on First Affiliated Hospital of Chongqing Medical University,Chongqing,Chongqing,China [8]National Center for Applied Mathematics,Shenzhen,Guangdong,China

出　　处：《General Psychiatry》2023年第4期248-259,共12页综合精神医学（英文）

基　　金：This research was supported by the following funds:Shenzhen Science and Technology Innovation Commission(KCXFZ20201221173400001,KCXFZ20201221173411032,SGDX20210823103805042);Natural Science Fund of Guangdong Province(2021A1515010983);Shenzhen Key Medical Discipline Construction Fund(no.SZXK005).

摘　　要：Background Somatic symptom disorder(SSD)commonly presents in general hospital settings,posing challenges for healthcare professionals lacking specialised psychiatric training.The Neuro-11 Neurosis Scale(Neuro-11)offers promise in screening and evaluating psychosomatic symptoms,comprising 11 concise items across three dimensions:somatic symptoms,negative emotions and adverse events.Prior research has validated the scale’s reliability,validity and theoretical framework in somatoform disorders,indicating its potential as a valuable tool for SSD screening in general hospitals.Aims This study aimed to establish the reliability,validity and threshold of the Neuro-11 by comparing it with standard questionnaires commonly used in general hospitals for assessing SSD.Through this comparative analysis,we aimed to validate the effectiveness and precision of the Neuro-11,enhancing its utility in clinical settings.Methods Between November 2020 and December 2021,data were collected from 731 patients receiving outpatient and inpatient care at Shenzhen People’s Hospital in China for various physical discomforts.The patients completed multiple questionnaires,including the Neuro-11,Short Form 36 Health Survey,Patient Health Questionnaire 15 items,Hamilton Anxiety Scale and Hamilton Depression Scale.Psychiatry-trained clinicians conducted structured interviews and clinical examinations to establish a gold standard diagnosis of SSD.Results The Neuro-11 demonstrated strong content reliability and structural consistency,correlating significantly with internationally recognised and widely used questionnaires.Despite its brevity,the Neuro-11 exhibited significant correlations with other questionnaires.A test-retest analysis yielded a correlation coefficient of 1.00,Spearman-Brown coefficient of 0.64 and Cronbach’sαcoefficient of 0.72,indicating robust content reliability and internal consistency.Confirmatory factor analysis confirmed the validity of the three-dimensional structure(p<0.001,comparative fit index=0.94,Tucker-Lewis ind

关 键 词：validity dimensions SPITE 

分 类 号：R74[医药卫生—神经病学与精神病学]